First AD

Second AD

Summary and Forward Looking for RCC

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Insights

Insights is an expert interview video series of leading oncologists that provides in-depth reports and feature segments profiling leaders in a range of oncology disciplines, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, and hematologic malignancies. Most episodes feature 2 clinicians discussing the latest oncology advances in clinical practice. 

Video Series

My Treatment Approach: Translating Evidence to Clinical Practice in Advanced RCC  

In her concluding remarks, Laurence Albiges, MD, PhD, shares her final thoughts and expresses optimism for the future landscape of renal cell carcinoma treatments. 

Summary and Forward Looking for RCC   

Evolving Treatment Standards in Non-Clear Cell RCC 

Extended Follow Up of KEYNOTE-B61 

Ongoing Clinical Trials in the front-line setting of advanced non-clear cell RCC 

STELLAR 304: Zanzalintinib plus nivolumab in non-clear cell RCC 

Case Presentation: 61-year-old male Renal Cell Carcinoma   

Use of Combination Regimens in Frontline RCC 

Treatment Decision Making in first-line combinations for advanced RCC 

AE Management for Combination Regimens in Advanced RCC 

Optimizing Treatment in Advanced RCC 

Dr Albiges Discusses a Non-Clear Cell RCC Patient Profile   

Updates in the Treatment Approach for Non-clear cell RCC 

Dr Albiges Reviews Long term follow up data from KEYNOTE-B61 

Emerging Therapies in the Front-line Setting of Advanced non-clear cell RCC 

Biomarker-driven combination treatment approach in non-clear cell RCC (Met-driven) 